{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:42:12Z","timestamp":1786984932645,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.autrev.2018.03.011","type":"journal-article","created":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T20:58:49Z","timestamp":1531256329000},"page":"866-872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: Analysis of a cohort of 214 patients"],"prefix":"10.1016","volume":"17","author":[{"given":"Romain","family":"Paule","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Le Guern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Fredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Coutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriem","family":"Belhocine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"le Jeunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Chauvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Piette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2018.03.011_bb0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2018.03.011_bb0010","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.autrev.2016.07.028","article-title":"APS - diagnostics and challenges for the future","volume":"15","author":"Pengo","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.03.011_bb0015","first-page":"926","article-title":"Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?","volume":"31","author":"Berman","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2018.03.011_bb0020","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/art.1780150512","article-title":"Criteria for the classification of systemic lupus erythematosus\u2014status 1972","volume":"15","author":"Cohen","year":"1972","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.03.011_bb0025","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.03.011_bb0030","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.03.011_bb0035","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1191\/0961203304lu2019oa","article-title":"Classification criteria for systemic lupus erythematosus: a review","volume":"13","author":"Petri","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2018.03.011_bb0040","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.03.011_bb0045","first-page":"1835","article-title":"Systemic lupus erythematosus and the antiphospholipid syndrome: reflections about the relevance of ARA criteria","volume":"19","author":"Piette","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.03.011_bb0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.revmed.2013.11.011","article-title":"The new classification criteria for systemic lupus erythematosus (SLICC)","volume":"35","author":"Costedoat-Chalumeau","year":"2014","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.autrev.2018.03.011_bb0055","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2018.03.011_bb0060","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1136\/ard.2004.025759","article-title":"Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome","volume":"64","author":"Cervera","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.03.011_bb0065","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.autrev.2010.08.005","article-title":"Catastrophic antiphospholipid syndrome: updated diagnostic algorithms","volume":"10","author":"Erkan","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.03.011_bb0070","first-page":"1802","article-title":"Exclusion criteria for primary antiphospholipid syndrome","volume":"20","author":"Piette","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.03.011_bb0075","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.03.011_bb0080","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.03.011_bb0085","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.03.011_bb0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2018.03.011_bb0095","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2018.03.011_bb0100","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.03.011_bb0105","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3899\/jrheum.161364","article-title":"Longterm outcome of patients with primary antiphospholipid syndrome: a retrospective multicenter study","volume":"44","author":"Taraborelli","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.03.011_bb0110","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2215\/CJN.00460110","article-title":"Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients","volume":"5","author":"Sinico","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2018.03.011_bb0115","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005792-198911000-00004","article-title":"The \u201cprimary\u201d antiphospholipid syndrome: major clinical and serological features","volume":"68","author":"Asherson","year":"1989","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2018.03.011_bb0120","first-page":"1801","article-title":"SLE and the antiphospholipid antibody syndrome","volume":"20","author":"Asherson","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.03.011_bb0125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jaut.2009.02.008","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \u201cCAPS Registry.\u201d","volume":"32","author":"Cervera","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.03.011_bb0130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.V103507","article-title":"The intrarenal vascular lesions associated with primary antiphospholipid syndrome","volume":"10","author":"Nochy","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2018.03.011_bb0135","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.autrev.2016.09.010","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry","volume":"15","author":"Rodr\u00edguez-Pint\u00f3","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.03.011_bb0140","first-page":"482","article-title":"Primary antiphospholipid syndrome","volume":"16","author":"Alarc\u00f3n-Segovia","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.03.011_bb0145","first-page":"2242","article-title":"T lymphocyte subsets in primary antiphospholipid syndrome","volume":"21","author":"Papo","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.03.011_bb0150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/0961203310395052","article-title":"Task force on catastrophic antiphospholipid syndrome (APS) and non-criteria APS manifestations (II): thrombocytopenia and skin manifestations","volume":"20","author":"Cervera","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2018.03.011_bb0155","first-page":"115","article-title":"High frequency of C4 \u201cnull\u201d alleles in primary antiphospholipid syndrome","volume":"147","author":"Bentolila","year":"1996","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.autrev.2018.03.011_bb0160","article-title":"Genome-wide association study of antiphospholipid antibodies","volume":"2013","author":"Kamboh","year":"2013","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.autrev.2018.03.011_bb0165","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/ard.2008.090670","article-title":"Complement activation in patients with primary antiphospholipid syndrome","volume":"68","author":"Oku","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.03.011_bb0170","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.autrev.2016.07.020","article-title":"Complement and thrombosis in the antiphospholipid syndrome","volume":"15","author":"Oku","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.03.011_bb0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01.md.0000172074.53583.ea","article-title":"Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?","volume":"84","author":"G\u00f3mez-Puerta","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2018.03.011_bb0180","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood-2010-05-283507","article-title":"Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study","volume":"116","author":"Comellas-Kirkerup","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.03.011_bb0185","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-2776(08)60777-4","article-title":"Immunology and clinical importance of antiphospholipid antibodies","volume":"49","author":"McNeil","year":"1991","journal-title":"Adv Immunol"},{"key":"10.1016\/j.autrev.2018.03.011_bb0190","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.03.011_bb0195","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.autrev.2017.07.012","volume":"16","author":"Giacomelli","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.03.011_bb0200","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.autrev.2017.05.006","article-title":"Refractory obstetrical antiphospholipid syndrome: features, treatment and outcome in a European multicenter retrospective study","volume":"16","author":"Mekinian","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.03.011_bb0205","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3899\/jrheum.130704","article-title":"American College of Rheumatology criteria at inception, and accrual over 5\u202fyears in the SLICC inception cohort","volume":"41","author":"Urowitz","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.03.011_bb0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0961203313512883","article-title":"The American College of Rheumatology and the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus in two multiethnic cohorts: a commentary","volume":"23","author":"Pons-Estel","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2018.03.011_bb0215","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/acr.22539","article-title":"Classification of systemic lupus erythematosus: systemic lupus international collaborating clinics versus American College of Rheumatology Criteria. A comparative study of 2,055 patients from a real-life, international systemic lupus erythematosus cohort","volume":"67","author":"In\u00eas","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2018.03.011_bb0220","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/acr.22422","article-title":"Performance of the 2012 Systemic Lupus International Collaborating Clinics and the 1997 American College of Rheumatology classification criteria for systemic lupus erythematosus in a real-life scenario","volume":"67","author":"Amezcua-Guerra","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2018.03.011_bb0225","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.autrev.2018.01.007","volume":"17","author":"Hartman","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.03.011_bb0230","article-title":"Developing and refining new candidate criteria for systemic lupus erythematosus classification: an international collaboration","author":"Tedeschi","year":"2017","journal-title":"Arthritis Care Res"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218301563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218301563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T01:35:07Z","timestamp":1661564107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997218301563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1568997218301563"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.03.011","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: Analysis of a cohort of 214 patients","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}